PD-L1 Clinical Trials

13 clinical trials for PD-L1 across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• 68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers — RECRUITING
• LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study — RECRUITING · PHASE1
• A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications. — RECRUITING
• Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial. — RECRUITING · PHASE2
• PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor — NOT_YET_RECRUITING
• PD-L1 Antibody Combined With CTLA-4 Antibody for Patients With Advanced Intrahepatic Cholangiocarcinoma Who Progressed After Standard Treatment — ACTIVE_NOT_RECRUITING · PHASE2
• Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC — NOT_YET_RECRUITING · PHASE2
• Radiomics for prEdiction of lunG cAncer biologY — OTHER
• PD-L1 Targeting Nanobody Probe for PET Imaging of Solid Tumor — OTHER · NA
• Immune Profiling After HDR in Local Relapsed Prostate Cancer — COMPLETED
• Genetic Mutation in Epithelial Ovarian Cancer — OTHER
• Genetic Mutation in Recurrent Cervical Cancer — OTHER
• Effect of Chemotherapy on PD-L1 in NSCLC — OTHER

Refine this search